Form D · Pharmaceuticals
Insigna, Inc.
Champaign, IL · CIK 0001780356
Offering snapshot reported Jul 8, 2025 · SEC filing
- Reported sold
- $4M Indefinite offering
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Jan 22, 2025 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$2,000,016 → $4,000,032
- Reported investors0 → 2
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 8, 2025 | Amendment | $4,000,032 | $2,000,016vs Feb 18, 2025 | 2 | SEC filing |
| Feb 18, 2025 | Initial | $2,000,016 | No comparison | 0 | SEC filing |
| Mar 10, 2023 | Amendment | $1,166,927 | $1,069,944vs Dec 27, 2022 | 7 | SEC filing |
| Dec 27, 2022 | Initial | $96,983 | No comparison | 4 | SEC filing |
| Aug 10, 2022 | Initial | $2,000,000 | No comparison | 1 | SEC filing |
| Jun 21, 2019 | Initial | $1,368,400 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-538511
Amendment filed to reflect second closing on July 1, 2025.
Source: Form D, filed Jul 8, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Che Myong Jay Ko | Director, Executive |
| Byron Alexandrovich Wittenberg | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:Champaign, IL, 61820
Phone: 833-565-4771